Susan G. Komen and Amgen to Help People Understand and Monitor Breast and Bone Health

On May 19, 2021 Susan G. Komen, the world’s leading breast cancer organization, reported a new integrated campaign, in partnership with Amgen, to educate the breast cancer community about the link between breast and bone health, providing useful information for women of all ages and stages of breast cancer (Press release, Amgen, MAY 19, 2021, View Source [SID1234580299]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"Breast cancer treatment can affect bone health, and it is one of main areas where breast cancers spread when they metastasize. Yet no matter your age, health or breast cancer diagnosis, your bone health may also be at risk," said Paula Schneider, president and CEO of Susan G. Komen and a breast cancer survivor. "Women have long known that it is important to understand what is normal for their breast health and to talk to their doctor if they notice any changes. Women need to include their bones in this moment of vigilance."

Metastatic breast cancer, also known as stage IV breast cancer, is when the breast cancer spreads beyond the breast and nearby lymph nodes to other parts of the body, often the bones. When breast cancer cells spread to the bones, lesions can occur that cause the bones to break easily and may result in spinal cord compression. Research shows that 70 percent of women with bone metastasis will have a skeletal related event within two years of diagnoses. All of these skeletal complications can lead to chronic pain and the loss of mobility.

Through a mixture of facts and personal storytelling, the integrated campaign will drive people to komen.org/breast-and-bone-health, where women will be provided useful information about their breast and bone health, including:

Questions to ask your doctor about metastatic breast cancer and bone protection
How to protect bones from fractures and other problems, including through diet
What treatments may negatively impact bone health
What drugs are available to improve bone density
Amgen also provides additional information for people living with metastatic breast cancer on its website – Let’s Talk Bone Mets.

Together, the two organizations seek to inspire people to learn more about their breast and bone health and become empowered to monitor their health and have constructive conversations with their health care teams.